EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 212 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,660,400 | -57.6% | 488,353 | -8.4% | 0.00% | -100.0% |
Q2 2023 | $3,918,248 | -29.3% | 533,095 | -0.4% | 0.00% | 0.0% |
Q1 2023 | $5,545,678 | -43.6% | 535,297 | -35.7% | 0.00% | -50.0% |
Q4 2022 | $9,836,100 | -44.4% | 832,862 | -1.1% | 0.00% | -50.0% |
Q3 2022 | $17,676,000 | -5.1% | 842,130 | +40.3% | 0.00% | 0.0% |
Q2 2022 | $18,633,000 | -26.3% | 600,318 | -2.6% | 0.00% | 0.0% |
Q1 2022 | $25,294,000 | +4.5% | 616,032 | +10.6% | 0.00% | 0.0% |
Q4 2021 | $24,204,000 | -47.5% | 556,771 | -39.5% | 0.00% | -50.0% |
Q3 2021 | $46,100,000 | -22.2% | 920,734 | -2.1% | 0.01% | -20.0% |
Q2 2021 | $59,257,000 | -17.4% | 940,733 | +21.8% | 0.01% | -23.1% |
Q1 2021 | $71,766,000 | -0.3% | 772,431 | -3.8% | 0.01% | -7.1% |
Q4 2020 | $71,980,000 | -12.8% | 803,336 | +0.6% | 0.01% | -22.2% |
Q3 2020 | $82,529,000 | +36.7% | 798,696 | +4.6% | 0.02% | +28.6% |
Q2 2020 | $60,366,000 | -1.7% | 763,355 | -28.1% | 0.01% | -22.2% |
Q1 2020 | $61,428,000 | +10.1% | 1,061,674 | +2.6% | 0.02% | +50.0% |
Q4 2019 | $55,816,000 | -0.1% | 1,034,592 | -3.2% | 0.01% | -7.7% |
Q3 2019 | $55,851,000 | +15.4% | 1,068,297 | +6.7% | 0.01% | +18.2% |
Q2 2019 | $48,378,000 | +6.1% | 1,001,419 | +11.0% | 0.01% | 0.0% |
Q1 2019 | $45,597,000 | -11.2% | 902,561 | +4.2% | 0.01% | -21.4% |
Q4 2018 | $51,371,000 | -19.9% | 866,570 | -11.0% | 0.01% | -12.5% |
Q3 2018 | $64,121,000 | +10.4% | 974,036 | -15.3% | 0.02% | +6.7% |
Q2 2018 | $58,072,000 | +6.8% | 1,150,184 | +11.3% | 0.02% | +7.1% |
Q1 2018 | $54,392,000 | +13.2% | 1,033,086 | -0.1% | 0.01% | +16.7% |
Q4 2017 | $48,038,000 | +14.0% | 1,033,732 | -0.7% | 0.01% | +9.1% |
Q3 2017 | $42,124,000 | +37.0% | 1,041,385 | +14.9% | 0.01% | +22.2% |
Q2 2017 | $30,747,000 | +71.9% | 906,731 | +47.2% | 0.01% | +80.0% |
Q1 2017 | $17,885,000 | -8.8% | 615,868 | +3.1% | 0.01% | -16.7% |
Q4 2016 | $19,619,000 | +13.0% | 597,406 | +8.5% | 0.01% | +20.0% |
Q3 2016 | $17,361,000 | +15.4% | 550,649 | +3.0% | 0.01% | 0.0% |
Q2 2016 | $15,038,000 | -16.1% | 534,798 | +8.3% | 0.01% | -16.7% |
Q1 2016 | $17,932,000 | -7.6% | 493,659 | +1.8% | 0.01% | 0.0% |
Q4 2015 | $19,406,000 | +38.6% | 485,023 | -1.3% | 0.01% | +20.0% |
Q3 2015 | $14,001,000 | +2.5% | 491,448 | +18.6% | 0.01% | +25.0% |
Q2 2015 | $13,658,000 | +32.1% | 414,485 | +15.3% | 0.00% | +33.3% |
Q1 2015 | $10,339,000 | +8.8% | 359,503 | +3.0% | 0.00% | 0.0% |
Q4 2014 | $9,507,000 | +24.6% | 349,101 | -2.5% | 0.00% | +50.0% |
Q3 2014 | $7,628,000 | -4.6% | 357,952 | +0.5% | 0.00% | 0.0% |
Q2 2014 | $7,996,000 | -19.8% | 356,014 | -9.8% | 0.00% | -33.3% |
Q1 2014 | $9,975,000 | +2.5% | 394,774 | -6.7% | 0.00% | 0.0% |
Q4 2013 | $9,731,000 | +19.4% | 423,244 | -1.0% | 0.00% | 0.0% |
Q3 2013 | $8,147,000 | +34.0% | 427,671 | +1.4% | 0.00% | +50.0% |
Q2 2013 | $6,082,000 | – | 421,776 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
AtonRa Partners | 11,505 | $472,000 | 0.26% |